Literature DB >> 28894311

Pharmacy Student Facilitation of Reporting of Adverse Drug Reactions in a Hospital.

Jason Wentzell1, Tiffany Nguyen1, Stephanie Bui2, Erika MacDonald3.   

Abstract

BACKGROUND: Health Canada relies on health professionals to voluntarily report adverse reactions to the Canada Vigilance Program. Current rates of reporting adverse drug reactions (ADRs) are inadequate to detect important safety issues.
OBJECTIVE: To assess the impact of pharmacy student facilitation of ADR reporting by pharmacists at a tertiary care teaching hospital in Canada.
METHODS: The intervention of interest, implemented at one campus of the hospital, was facilitation of ADR reporting by pharmacy students. The students received training on how to submit ADR reports and presented information sessions on the topic to hospital pharmacists; the pharmacists were then encouraged to report ADRs to a designated student for formal reporting. Frequency of reporting by pharmacists at the intervention campus was compared with reporting at a control campus of the same hospital. Data were collected prospectively over a 6-month pilot period, starting in April 2015.
RESULTS: During the pilot period, 27 ADR reports were submitted at the intervention campus, and 3 reports at the control campus. All student participants strongly agreed that they would recommend that responsibility for submitting ADR reports to the Canada Vigilance Program remain with pharmacy students during future rotations.
CONCLUSIONS: Availability of a pharmacy student to facilitate reporting of ADRs may increase the frequency of ADR reporting and could alleviate pharmacist workload; this activity is also a potentially valuable learning experience for students.

Entities:  

Keywords:  adverse drug reaction; adverse drug reaction reporting; déclaration des réactions indésirables aux médicaments; hospital pharmacist; pharmacien d’hôpital; pharmacy student; réaction indésirable aux médicaments; étudiant en pharmacie

Year:  2017        PMID: 28894311      PMCID: PMC5587040          DOI: 10.4212/cjhp.v70i4.1677

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  4 in total

1.  Post-market drug evaluation research training capacity in Canada: an environmental scan of Canadian educational institutions.

Authors:  Matthew O Wiens; Judith A Soon; Stuart M MacLeod; Sunaina Sharma; Anik Patel
Journal:  J Popul Ther Clin Pharmacol       Date:  2014-10-19

2.  Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

Authors:  David J Graham; David Campen; Rita Hui; Michele Spence; Craig Cheetham; Gerald Levy; Stanford Shoor; Wayne A Ray
Journal:  Lancet       Date:  2005 Feb 5-11       Impact factor: 79.321

Review 3.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

4.  How safe are new drugs? Market withdrawal of drugs approved in Canada between 1990 and 2009.

Authors:  Joel Lexchin
Journal:  Open Med       Date:  2014-01-28
  4 in total
  3 in total

1.  Adverse Drug Reaction Reporting: Opportunities to Increase Pharmacists' Role.

Authors:  Stephen Shalansky
Journal:  Can J Hosp Pharm       Date:  2018-08-28

2. 

Authors:  Stephen Shalansky
Journal:  Can J Hosp Pharm       Date:  2018-08-28

3.  Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department.

Authors:  Mirjam Kauppila; Janne T Backman; Mikko Niemi; Outi Lapatto-Reiniluoto
Journal:  Eur J Clin Pharmacol       Date:  2020-11-13       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.